Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia

Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia

Abstract Introduction Mortality is elevated after prison release and may be higher in people with HIV and opioid use disorder (OUD). Maintenance with opioid agonist therapy (OAT) like methadone or buprenorphine reduces mortality in people with OUD and may confer benefits to people with OUD and HIV l...

Full description

Bibliographic Details
Main Authors: Alexander R. Bazazi, Gabriel J. Culbert, Martin P. Wegman, Robert Heimer, Adeeba Kamarulzaman, Frederick L. Altice
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Infectious Diseases
Subjects:
Methadone
HIV
Opioid use disorder
Prison
Mortality
Online Access:https://doi.org/10.1186/s12879-022-07804-6

Internet

https://doi.org/10.1186/s12879-022-07804-6

Similar Items